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Serotonin is a classical small-molecule neurotransmitter with known effects on developmental processes. Previous studies have shown a
developmental role for serotonin in the fly peripheral nervous system. In this study, we show that serotonin can modulate the development of
serotonergic varicosities within the fly central nervous system. We have developed a system to examine the development of serotonergic
varicosities in the larval CNS. We use this method to describe the normal serotonergic development in the A7 abdominal ganglion. From first
to third instar larvae, the volume of the neuropil and number of serotonergic varicosities increase substantially while the varicosity density
remains relatively constant. We hypothesize that serotonin is an autoregulator for serotonergic varicosity density. We tested the sensitivity of
serotonergic varicosities to serotonin by adding neurotransmitter at various stages to isolated larval ventral nerve cords. Addition of excess
exogenous serotonin decreases native varicosity density in older larvae, and these acute effects are reversible. The effects of serotonin appear
to be selective for serotonergic varicosities, as dopaminergic and corazonergic varicosities remain qualitatively intact following serotonin
application.
D 2005 Elsevier Inc. All rights reserved.Keywords: Neurite formation; Neurotransmitter; CNS developmentIntroduction
Small-molecule neurotransmitters such as serotonin are
important modulatory signals in neuronal development
(Gaspar et al., 2003). In general, synaptic neuropil is almost
always broadly and evenly innervated with serotonergic
varicosities such that all regions should receive equal
quantities of serotonin (Bunin and Wightman, 1998).
Serotonergic varicosities, like those of other neuromodula-
tory neurons, are thought to engage primarily in volumetric-
type neurotransmission in which neurotransmitter is released
for distribution over a region of neuropil containing many
target synapses (Bunin and Wightman, 1999). As such,0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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partners. While serotonergic varicosity density should be
very important for function and seems to be constant for a
given brain region (Oleskevich and Descarries, 1990), it is
unclear how serotonergic varicosity formation is spatially
regulated. One role for serotonin may be to autoregulate the
spacing of neuronal processes. In general, neurons form
synapses in a space-filling manner such that volume coverage
is maximized (Panico and Sterling, 1995). This process is
similar to tiling in sensory dendrites in which the distributive
spacing of neuronal processes make receptive fields non-
redundant (Jan and Jan, 2003). While a number of molecules
are known to regulate these spatially complex processes, it is
as yet unclear what the mechanism is (Zinn, 2004).
The neuropil within the fly CNS has distinct anatomical
landmarks that can be reproducibly discriminated between
samples (Landgraf et al., 2003). Identification of the 84
serotonergic neurons within the fly ventral nerve cord is286 (2005) 207 – 216
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markers and a predictable anatomical distribution (Valles
and White, 1988). Serotonin immunoreactivity and seroto-
nin uptake are confined to the serotonergic neurons, which
also express the serotonin biosynthesis enzyme dopa
decarboxylase (Ddc, involved in serotonin and dopamine
synthesis) (Lundell and Hirsh, 1994). The dopaminergic
neurons are also distinct from the serotonergic neurons
(Budnik et al., 1986; Valles and White, 1986), though the
dopaminergic neurites are found in the same general regions
as those of the serotonergic system. The regular structure of
the fly CNS allows for consistent identification of particular
regions of synaptic neuropil from different animals.
Serotonin is known to modulate neuronal branch spac-
ing. The number of serotonergic varicosities in the
peripheral nervous system (PNS) of Drosophila doubles
when serotonin and dopamine synthesis is reduced (Budnik
et al., 1989), suggesting that endogenous serotonin acts to
maintain proper neuronal architecture, and that removing
this inhibitory influence causes excess branching. The
Helisoma serotonergic neuron ENC1 (embryonic neuron
C1) increases its branch density when p-chlorophenylala-
nine (inhibits tryptophan hydroxylase resulting in decreased
serotonin synthesis) is administered, while 5-hydroxytryp-
tophan, which increases serotonin levels and decreases the
number of branch points (Diefenbach et al., 1995). The
response of neuronal processes to serotonin in vitro has been
characterized in a number of systems by examining the
formation and retraction of growth cones (Torreano et al.,
2005; Koert et al., 2001). In some cell types, serotonin
inhibits growth cone mobility through activation of voltage-
dependent calcium channels (Kater and Mills, 1991). The
Helisoma glutamatergic buccal ganglion neuron 19 (B19)
demonstrates marked inhibition of its growth cone by
serotonin (Haydon et al., 1984); these effects can be
mimicked by electrical activity (Cohan and Kater, 1986)
and blocked by acetylcholine (McCobb et al., 1988).
We have developed a method to measure the modulatory
effects of serotonin on serotonergic neurite spacing in the
Drosophila CNS. The native structure of the nerve cord is
preserved using a cultured explant strategy, and spinning
disk confocal microscopy was used to capture and
reconstruct the three-dimensional arrangement of the sero-
tonergic neuropil. As serotonergic neurons develop, seroto-
nin may act as an autocrine/paracrine signal to direct the
formation and retraction of varicosities within neuropil to
maximize innervation within the tissue and prevent exube-
rant connections from persisting.Materials and methods
Fly stocks
The following fly stocks were obtained from Blooming-
ton stock center (http://flystocks.bio.indiana.edu/): CantonS(CS); OregonR (OR); UAS-mCD8-GFP; UAS-syb-GFP;
ddc-GAL4; egmz360; and ddc P-element insertion (y1
w67c23;P{w + mC = lacZ}Ddck02104/CyO). The TH-
GAL4 stock was a gift from Jay Hirsh (University of
Virginia).
Preparation of ventral nerve cords (VNCs)
Age-matched larval VNCs were dissected in Schneider’s
insect media (25-C) and mounted to #1 glass microscope
coverslips (18 mm2) in 2 mL fresh media. Serotonin (5-
hydroxytryptamine; Sigma, St. Louis, MO) was dissolved in
dH2O and diluted 1:1000 with fresh insect media for VNC
applications. Tissue fixation was by adding 4 mL of fresh 4%
paraformaldehyde for 60 min (3% final PFA concentration),
followed by washing with 1 PBS and 1 PBT. Samples
were incubated with primary antibodies overnight at 4-C, in
2 mL 1 PBT with 1:667 anti-serotonin (rabbit polyclonal,
ImmunoStar) and 1:2000 anti-GFP (3E6 mouse monoclonal,
Molecular Probes), except UAS-CD8-GFP;TH-GAL4 where
anti-5HTwas omitted and CantonS and OregonR, where anti-
GFP was omitted. Secondary antibodies (fluorescein-con-
jugated goat-anti-mouse and rhodamine-conjugated goat-
anti-rabbit) were obtained from Jackson Laboratories, and
used 1:1000 in 2 mL 1 PBT, overnight at 4-C. All
immunostained VNCs were mounted to microscope slides in
90% glycerol/2.5% DABCO (Sigma) and stored at 20-C
prior to imaging. The Ab7 left ganglion was imaged from all
samples.
Varicosity measurement and visualization
Samples were imaged with a Nikon eclipse E800
microscope (100, oil-immersion lens, NA = 1.3), Hama-
matsu ORCA-ER camera, and a Perkin-Elmer spinning disc
confocal unit. The microscope and camera were calibrated
using a micron scale (Sigma) and the Focal Check
Fluorescent Microspheres Kit (6 Am, Molecular Probes, F-
24633). The distal abdominal ganglia were imaged from the
cell bodies through the dorsal surface of the neuropil (250–
600 optical slices) with 1  1 binning and 0.094-Am-thick
sections. Exposure times varied from 150 to 1000 ms,
depending on the intensity of the immunofluorescence
(typical exposure ¨300 ms). These parameters over-sample
the tissue such that the resolution limit of light microscopy
is the limiting factor for visualization. Serial images were
auto-leveled in Adobe Photoshop and then imported into
Volocity 2.0 for 3-dimensional rendering and varicosity
quantification. Each VNC processed generates approxi-
mately 1 GB of data and takes a minimum of 1.5 h of
computational processing time with a Macintosh PowerPC
G4. Varicosities were classified within the anatomical
boundaries of the A7 ganglia. To manually measure
varicosity volume, varicosities were identified in single
confocal slices. Varicosities were defined as swellings in
branches in which the swelling was at least twice the
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were assumed to be ellipsoids with the major axis along the
branch, and the first minor axis as the width. The second
minor axis, which would be perpendicular to the plane of
the photograph, was assumed to be the same as the first
minor axis. For manual density measures, varicosities were
counted in a single confocal slice of defined area. As
varicosities are about 0.5–1.0 Am, it was estimated that each
slice represented varicosities in a 1-Am-thick slice. There-
fore, the 3D density could be estimated. For each sample,
density measures were taken at 2-Am intervals through a
sample (about 20 slices) and averaged.
Varicosities and synapses may be functionally distinct.
Synapses indicate a region of direct communication between
two neuronal processes, with a characteristic profile under
electron microscopy, whereas varicosities describe pre-
synaptic swellings that contain a variety of vesicular
proteins and neurotransmitter (Ahmari et al., 2000).
Previous studies have characterized varicosities as bio-
chemical isolates containing various proportions of synaptic
vesicles and mitochondria; while varicosities vary in size,
rodent varicosities have been generally characterized as
>0.4 Am in diameter, while the intra-varicosity neurite seg-
ments are <0.4 Am in diameter (Dori et al., 1998; Shepherd
and Harris, 1998).
The signal from the entire intensity distribution was
included for analysis, with a size (i.e., volume) inclusion
range of 0.2–8 Am3, and Volocity options for noise
reduction and object separation were selected. Sample
density was calculated by Volocity-counting the number of
varicosities within a rectangular solid of known volume
from the central region of the neuropil, excluding the gaps at
the edges of the neuropil.
The Tukey–Kramer Multiple Comparisons Test and
ANOVA analyses were performed for all statistical compa-
risons using Graphpad InStat 3.0 for Macintosh. These tests
evaluate whether the means of three or more independent
variables differ. All graphs were constructed using Graph-
pad Instat for Macintosh and mean T SD are shown in all
figures. For each data point, 6 samples were used.Results
Serotonergic structure within the ventral nerve cord
The 7th abdominal ganglia (Ab7) of the Drosophila
larval ventral nerve cord (VNC) were selected as the
anatomical region for all analyses (Campos-Ortega and
Hartenstein, 1985). This region has a regular anatomy, and
can be consistently identified between sample nerve cords
of different developmental stages (Figs. 1A, B). Larval
development is divided into three instar phases: first (L1)
and second (L2) instar correspond to the first and second
days following embryogenesis, respectively, while third
instar (L3) begins on the third day after embryogenesis andlasts until pupation (around day 6). Third instar larvae can
further be classified on the basis of behavior, with early L3
larvae foraging for food (L3-F, around 72 h post-hatching)
and late L3 larvae wandering prior to pupation (L3-W,
around 120 h post-hatching). Serotonergic neurons are
located in the ventral region of the VNC, and extend
neurites into the neuropil (Figs. 1A–D). Dopaminergic
neurons are distributed into two main groups: dorsal lateral
dopaminergic neurons, which are lateral to the serotonergic
neurons, and medial dopaminergic neurons, located ven-
trally to the serotonergic neurons (Fig. 1B) (Lundell and
Hirsh, 1994). In addition, lateral to the serotonergic neurons
is a non-serotonergic, ddc-positive corazonergic neuron,
which contributes to the central region of neuropil (Fig. 1D,
green) (Landgraf et al., 2003). Dopaminergic and corazo-
nergic (i.e., ddc-positive, serotonin-negative) branching in
these ganglia begins around second instar (2 days), after
serotonergic neurons have established a general region of
distribution, and contributes to the central and dorsal
varicosities; these processes continue to develop into third
instar (Figs. 1C, D). As the larvae mature from L1 to L3,
serotonergic neurites in this region increase and the volume
of the Ab7 expands while maintaining varicosity density
and general architecture (Figs. 1E, F). The volume of the
neuropil increases from 5637 T 794 Am3 at L1 to 27333 T
1398 Am3 at L3-W (n = 6). Colocalization of serotonin with
the GFP-labeled synaptic vesicle protein synaptobrevin
(syb-GFP; Zhang et al., 2002) is shown for a representative
region of serotonergic neuropil from a first instar UAS-syb-
GFP;egmz360 larval VNC (Figs. 1G, H). Note that the
serotonin-immunoreactive swellings (red) colocalize with
synaptobrevin-GFP (green). Non-serotonergic varicosities
in Figs. 1G, H are from the corazonergic neuron, which also
expresses egGAL4. Syb-GFP puncta are 0.92 T 0.15 Am in
diameter (n = 44), which corresponds to a volume of 0.45 T
0.23 Am3 assuming these are spheres. This matches well
with serotonergic varicosity structure in the vertebrate
cortex (Cohen et al., 1995). Note that serotonin immuno-
reactivity is diffuse throughout the entire cell, filling the
soma, nucleus, and fine processes. This finding is consistent
with serotonin immunohistochemical staining from grass-
hopper, and is not likely to be an artifact of the fixation or
staining process (Condron, 1999).
Quantifying varicosity density
A method to measure varicosity volume and density was
developed. Serotonergic varicosities in the Ab7 region were
visually identified as serotonin-immunoreactive swellings
larger than the intervening branches in a third instar VNC
(Figs. 2A, B). The volume of these swellings was deter-
mined manually and by using Volocity 2.0 software;
the distribution of varicosity volumes is shown in Fig. 2C.
The average varicosity volume for this selection was 0.7 T
0.2 Am3, and most volumes are between 0.2–8.0 Am3
(assuming a true sphere, this corresponds to an axial diameter
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typically represent intervening branch structures of the
neurites. Note that the limit of resolution using confocal
microscopy is about 0.25 Am in length, corresponding to
a spherical volume of 0.065 Am3, which is 10-fold smaller
than the structures of interest. Varicosity density was
calculated from manual identification of varicosities in serial
sections of neuropil and compared with computer-assisted
density calculations (Fig. 2D). A series of VNCs were
repeatedly processed (following an overnight freeze–thaw
cycle), and the number of varicosities within the Ab7 region
was independently determined (data not shown). Thesampling error using this method is 7.1 T 3.2%, which
accounts for errors due to image acquisition, photobleaching,
and user-defined selection of the anatomical region of interest
as well as computerized classification of varicosities. This
error is smaller than the error between age-matched VNCs
(Fig. 2E) and is not thought to significantly skew further
analyses.
Varicosity density during development
Varicosity density measurements from wild-type (wt)
larvae were made to establish a normal development curve
(Fig. 2E). Varicosities are added throughout the larval
period as the VNC increases in size and complexity. The
varicosity density remains about the same from L1 to L3-F,
but becomes increasingly variable as the larvae approach
pupation. There is no significant difference between the
isogenic UAS-mCD8-GFP;ddc-GAL4 (doubly homozy-
gous) (Lee and Luo, 1999; Li et al., 2000) and two classic
wild-type fly strains (Oregon R and Canton S) during the
larval period (Fig. 2E). The UAS-mCD8-GFP;ddc-GAL4 fly
line was used as a control for all further studies; this strain
expresses membrane-localized GFP in all cells expressing
ddc (dopa decarboxylase). In the VNC, the serotonergic,
dopaminergic, and corazonergic cells are labeled with
mCD8-GFP (Lee and Luo, 1999; Novotny et al., 2002).
Serotonin levels modulate varicosity formation
Previous studies have suggested that decreased levels of
serotonin increase the number of serotonergic varicosities in
the PNS (Budnik et al., 1989). Deficits in dopa decarbo-
xylase function were examined using a mutant with aFig. 1. Characterization of serotonergic neuronal architecture. (A) Low-
magnification photomicrograph of the posterior L3 abdominal ganglia. (B)
Cartoon version of panel A. The last three segments, A6, A7, and A8, have
bilateral pairs of serotonergic neurons. All of these studies have focused on
the A7 ganglion. This is the most easily visualized and discerned in the
preparations. The red shows serotonin staining and the green shows GFP
staining. GFP was expressed using ddc-GAL4 which labels serotonergic
and dopaminergic neurons. In the A7 ganglion, the dopaminergic cell
bodies are dorsal/lateral as well as medial/ventral and are cropped out from
panel A. Anterior is at the top of the image. Panel C shows the confocal
high-resolution image of the region shown in the white square. The view is
from the ventral side of the ganglion, looking up through the cell-body layer
and into the neuropil. (D) Same as panel C, except rotated 90- such that
dorsal is now at the top of the image. Serotonergic varicosities (red/green)
fill the majority of the neuropil. The green dopaminergic and corazonergic
varicosities occupy mostly the more central regions of the neuropil. This
view is used throughout the rest of this article. (E) Serotonin staining only
of L1 segment. (F) Serotonin staining only of L3 segment. Note that the
varicosity density and pattern is similar between the two stages except that a
large increase in volume has occurred. (G) GFP staining of L1 ganglion in
which a GFP–synaptobrevin fusion was driven by egGAL4. This protein
should localize to presynaptic junctions. (H) Same as panel G except that
serotonin staining is in red and GFP staining is in green. Serotonin-stained
varicosities are labeled by punctate GFP staining. The green/non-
serotonergic varicosities are due to the corazonin-expressing neuron that
also expresses egGAL4. Scale bar = 5 Am.
P.A. Sykes, B.G. Condron / Developmental Biology 286 (2005) 207–216 211P-element insertion in the ddc gene: homozygous larvae
were identified as described (Budnik et al., 1989). These
larvae were very slow growing, and at larval day 6, the
homozygous mutant resembled a second instar larvae (day
2) in size; these mutants had difficulty moving, and
appeared generally unhealthy. The development of the
larval cuticle is dependent upon ddc activity, contributing
to the gross phenotype of the larvae (Budnik et al., 1989).
This severe gross growth phenotype would confound any
interpretation of serotonergic varicosity density. All ddc
mutant larvae died prior to reaching an equivalent size to
day 3 wt larvae (around larval day 7).In order to further test the role of serotonin on varicosity
density, exogenous serotonin was added to intact VNCs in
culture to assay the effects on varicosity density at different
developmental time points. We systematically characterized
the development of wt varicosity density (Figs. 2E and 3A,
B), applied exogenous serotonin (Figs. 3C, D), and then
removed the exogenous serotonin and allowed for post-
treatment recovery (Figs. 3E, F). As a further measure of
serotonin selectivity, the effects of serotonin were measured
on the dopaminergic neurons only, using the UAS-CD8-
GFP/+;TH-GAL4/+ strain, which expresses CD8-GFP in
only tyrosine hydroxylase-expressing cells (i.e., dopaminer-
gic neurons) (Friggi-Grelin et al., 2003). Unlike serotonergic
varicosities, which exhibit a distinct phenotype upon
serotonin application (Fig. 3C), incubation of VNCs with
10 or 100 AM serotonin does not qualitatively appear to
decrease dopaminergic architecture in L3-F larvae, but
instead allows for an increase in dopaminergic branching
in the dorsal region of the neuropil (Figs. 3G, H).
Age-matched randomly sorted UAS-CD8-GFP;ddc-
GAL4 VNCs were placed into one of four treatment groups
(0, 1, 10, or 100 AM serotonin in insect media), incubated
for 3 h (25-C), and processed for serotonin immunofluo-
rescence. Varicosity density was measured for the seroto-
nergic neurons in the usual manner. Serotonergic varicosities
in L1 larvae are not responsive to serotonin; L2 and L3-F
larval VNCs exhibit a dose-dependent decrease in seroto-
nergic varicosity density as exogenous serotonin is
increased from 1 AM to 100 AM serotonin (Fig. 4A). The
effects of exogenous serotonin could be seen as early as 30Fig. 2. Determination of varicosity density during the larval period. (A)
Serotonin staining of an L3 segment. (B) Classified varicosities of panel
A. The different colors simply distinguish the adjacent varicosities. (C)
Comparison of varicosity volume as determined from automated
classification, as in panel B or by a manual method. In the manual
method, varicosities were assumed to be ellipsoids. The manual measure-
ment (n = 94) is a subset of the automatic distribution (n = 304) as
determined by ANOVA analysis. The middle line in each bar represents
the mean; the middle dashed lines the 50% CI, and the extent of the bar,
the 95% CI. (D) Density measurements by manual and automatic
classification. For manual measurements, varicosities, as defined by
swellings more than twice the thickness of a branch, were counted in 1-
Am-thick sections of a defined area. This was done for 20 sections in each
sample the area density averaged. The volumetric density was estimated
by assuming that the density was the same in all axes. For automatic
density measures, the x, y, z coordinates of each varicosity were
determined from the classified images and the density was determined
by the number of varicosities in the sample volume. (E) Changes in
varicosity density over development of the larva. L3-F indicates a third
instar foraging larva, at 72 h after hatching. L3-W represents a wandering
third instar larva at 120 h after hatching. Six samples from two wild-type
strains, OR = Oregon R, CS = Canton S, and one transgenic control strain,
CD = w1119;UAS-mCD8-GFP;ddcGAL4, are shown for the four time
points. The density stays about the same until the end of third instar where
the variation increases. (F) The absolute number of varicosities is shown
with the corresponding changes in neuropil volume for the A7 region. The
changes in varicosity density (E) are due to the coordinated growth of the
neuropil with addition of new serotonergic varicosities. *P < 0.05, **P <
0.01, ***P < 0.001. Scale bar = 5 Am.
Fig. 3. Exogenous serotonin modulates serotonergic varicosity structure. Left panels A, D, and G are serotonin (red) and GFP (green). Middle panels B, E, and
H are serotonin alone. Right panels C, F, and I are GFP alone. Panels J and K are GFP alone. The GFP in panels A–I is driven by ddcGAL4 and so labels
serotonergic, corazonergic, and dopaminergic neurons. The GFP in panels J and K is driven by TH-GAL4 and labels the dopaminergic neurons. Panels A–C
are control non-treated tissue. Panels D–F are after 30 min in 100 AM serotonin. Panels G–I are same as panels D–F except that the serotonin was washed out
and samples left sit in media for 30 min. Panel J is an untreated control while panel K was treated in the same way as panels D–F. 5HT-treated dopaminergic
branches (K) show a consistent extraneous growth at the dorsal part of the sample. Scale bar = 5 Am.
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observed if incubation continued for 3 h. The changes in
varicosity density following exogenous serotonin are
visually apparent (compare Figs. 3A, B with Figs. 3C, D),
and do not appear to disrupt the general organization of the
VNC. Serotonergic varicosities also decrease in volume
following treatment with serotonin, from 0.81 T 0.11 Am3
(L3-F control) to 0.73 T 0.06 Am3 with 10 AM serotonin (ns)
and to 0.58 T 0.07 Am3 with 100 AM serotonin (P < 0.001);
the distribution curve of varicosity volume does not change
its overall shape, but uniformly decreases in peak amplitude
as serotonin is increased (data not shown).The effects of exogenous serotonin on serotonergic
varicosities are reversible (Fig. 4B). Age-matched UAS-
CD8-GFP;ddc-GAL4 L3-F VNCs were randomly sorted
into groups and treated with either 0 or 100 AM serotonin
for 30 min. Then, the 0-AM control and one 100-AM
serotonin-treated group were fixed (Figs. 3A–D); the
remaining 100-AM serotonin-treated groups were washed
with fresh insect media to dilute the serotonin to less than
0.1 AM, and then incubated for an additional 10–180 min
(25-C) prior to fixation. All samples were processed for
serotonin immunofluorescence. The serotonin-treated/wash-
out VNCs regained 92% of the pre-treatment varicosity
Fig. 4. Varicosity density changes following application and removal of
exogenous serotonin. (A) Effect of serotonin levels on varicosity density.
Significance is each sample against same-stage 0 AM. (B) Recovery profile
of varicosity density after serotonin treatment. 100 AM serotonin was added
at 5 min into the experiment, washed out at 35 min. Samples were taken at 5
min, 35 min, 45 min, and 205 min. For panel B, significance is against time
0. *P < 0.05, ***P < 0.001.
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In addition, there was a continued increase (above pre-
treatment baseline) in varicosity density as the recovery time
extended to 3 h (Fig. 4B).
In order to verify that serotonin induces a loss of
serotonergic varicosities, a quantifiable GFP marker was
used. As ddc-GAL4 induces the expression of GFP in both
serotonergic and interspersed dopaminergic varicosities, it is
difficult to quantify the loss of serotonergic-GFP alone.
Therefore, another driver, egGAL4, was used which induces
expression in serotonergic and corazonergic neurons in the
L3 CNS (Fig. 5). The corazonergic branches are confined to
two small regions of the CNS (green regions in Fig. 4A) and
are generally not varicosity-classified as they form optically
non-resolved structures greater than the 8 Am3 size cutoff.
For density measurements, the midline region of neuropil
most populated by corazoneric processes was also excluded
from the analysis. Compared to control, serotonin induces a
significant loss of both GFP and serotonin. After washout,
densities of GFP- and serotonin-labeled varicosities return
to normal.Discussion
These studies indicate that although the CNS varicosity
pattern is very complex, with respect to the PNS, the overall
density of varicosities is largely regulated as the neuropilincreases in size by fivefold. Developing neurites growing
in two dimensions interdigitate through a process known as
tiling (Jan and Jan, 2003; Wassle et al., 1981), such that
each neuron can maximize the non-redundant spatial
distribution of a given area. As tiling occurs, many neurons
also begin synthesizing their own neurotransmitter (Nguyen
et al., 2001). In our study, we have focused upon spacing
within three dimensions, using density as a measure of
varicosity distribution.
Exogenous serotonin modulates varicosity density
The addition of exogenous serotonin causes a dose-
dependent decrease in varicosity density beginning in L2
larvae; however, serotonin has no significant effect on
varicosity density for L1 VNCs. These findings suggest
that the modulatory effects of serotonin on neuronal
structure are temporally regulated, and these sensitivities
of older larvae to serotonin may represent a molecular
change as larvae develop. Also, all varicosities may not be
equally responsive to serotonin. When exogenous serotonin
is added in increasing concentrations (Fig. 4A), the
decreases in varicosity density in second and third instar
larvae appear to settle at the same absolute levels, which
might represent set points, despite different initial volumes
of neuropil. Despite the known exogenous serotonin
concentrations in the media, the concentration of serotonin
within the neuropil remains unknown at present, due to
unknown diffusion characteristics through the glial barrier
of the VNC, as well as unknown degradative and uptake
kinetics for serotonin within an intact nervous system.
Changes in varicosity density account for most of the
effects following manipulation of serotonin levels. Previous
studies have utilized the ddc mutant to globally eliminate
serotonin (and consequently, dopamine) from the larvae
(Budnik et al., 1989). Our evaluation depends upon an
ability to stage larvae based upon size and age, and the
developmental deficiencies seen in the ddc mutant con-
found our interpretation of varicosity maturation levels in
the CNS.
Plasticity in the fly serotonergic system is modulated by
serotonin
The acute effects of increased exogenous serotonin are
reversible (Fig. 4B). Serotonergic varicosities are eliminated
following incubation with serotonin; dilution of serotonin to
less than 0.1 AM is permissive for the recovery of
serotonergic varicosities to levels comparable with pre-
treatment controls. Once recovery has occurred, the
serotonergic varicosity density remains stable for a pro-
longed period. These findings indicate the potential for rapid
turnover in serotonergic varicosities provided the appropri-
ate stimulus. Live imaging of the effects of serotonin may
provide a further method to evaluate the role of transmitter
on neuronal structure. The effects of serotonin are selective
Fig. 5. Exogenous serotonin reversible reduces serotonergic varicosity number. Left panels A, D, and G are serotonin (red) and GFP (green). Middle panels B, E,
and H are serotonin alone. Right panels C, F, and I are GFP alone. The GFP in panels A–I is driven by egGAL4 and so labels serotonergic and corazonergic
neurons. Panels A–C are control plain media-treated tissue. Panels D–F are after two 30-min washes of 100 AM serotonin. Panels G–I are after one 30-min
treatment in 100 AMserotonin followed by a 30-min media wash. (J) The density of GFP- and serotonin-labeled varicosities was measured for six samples of each
of the treatment cases shown in this figure. Both 5HTand GFP-labeled varicosities show a significant and recoverable loss after serotonin treatment. **P < 0.01,
***P < 0.001. Scale bar = 5 Am.
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disrupt the gross organization of the neuropil. When
serotonergic varicosities retract following exogenous sero-
tonin application in L3-F larvae, dorsal dopaminergic
branches appear to increase in complexity; this interaction
between the serotonergic and dopaminergic systems remains
an interesting area for future studies. In addition, evaluating
the pharmacological and genetic basis for dopaminergic
varicosity maturation may be possible using the UAS-CD8-
GFP;TH-GAL4 strain and the method outlined here for
serotonergic neurons.Extrasynaptic transmission of serotonin may change neurite
structure
The synaptic cleft concentrations of neurotransmitter
following release have been estimated in the rodent at 6 mM
serotonin, which is significantly greater than the affinity of
the mammalian 5HT1 receptors; however, once serotonin
diffuses into the extracellular space, its maximal concen-
tration of 55 nM is close to the receptor affinity and Km for
transport (Bunin and Wightman, 1998). Serotonin under
these conditions may diffuse more than 20 Am in the rodent
P.A. Sykes, B.G. Condron / Developmental Biology 286 (2005) 207–216 215brain following synaptic release (Bunin and Wightman,
1998). Such high serotonin levels likely facilitate extra-
synaptic transmission, as concentration-dependent diffusion
away from reuptake sites may allow for local spread and
receptor activation. Extrasynaptic volume transmission for
dopamine, a neurotransmitter with similar properties to
serotonin, shows a maximum transmitter concentration of
2–3 AM up to 100 Am away from the release site; these
levels are sufficient to activate all of the dopamine receptor
subtypes (Cragg et al., 2001). Those constraints which
influence dopamine volume transmission (such as uptake,
concentration in terminals and diffusion rates) are similar for
serotonin, suggesting that local transmitter release may have
a significant effect on local transmitter concentration, and
this field of influence may extend a significant distance from
the point of release. From the density measure, the average
radial spacing of serotonergic varicosities in the L3-W wt
larvae is 3.5 T 0.3 Am. Provided that serotonin is released at
concentrations comparable to dopamine, serotonergic vari-
cosities may be influenced by local extrasynaptic trans-
mission. Furthermore, ddc genetic mosaics in the fly result
in serotonergic neurons that do not adequately synthesize
serotonin; however, local transmitter spread within a
segment allows serotonergic neurons to acquire serotonin
from the contralateral sib neurons (Valles and White, 1990).
Varicosity identification accounts for anatomical variation
The structure of serotonergic neurites undergoes many
morphological changes during the larval period. Due to the
consistent anatomy of the fly VNC, varicosities from an
equivalent region can be measured in different samples,
regardless of subtle changes in tissue dimensions as the larvae
grow. Since the entire abdominal ganglia can be observed and
measured, sampling errors have been estimated to be less than
10% and less significant than the individual variation
between age-matched larval VNCs. Colocalization studies
of presynaptic proteins and serotonin indicate that the volume
distribution of varicosities is within the 0.2–8.0 Am3 range
used for Volocity classification, and that these regions are
likely to be active zones for transmitter release. Nascent
varicosities that have not reached the lower threshold of
0.2 Am3 may be missed by these arbitrary limits, though our
estimations are that >90% of all varicosities are appropri-
ately numerated using this process, and any excluded
varicosity population would be omitted in every sample.
Serotonin and varicosity formation
Changes in serotonin levels rapidly modulate varicosity
density within the developing fly CNS. Exposure of
serotonergic neurons to serotonin decreases varicosity
density in older larvae, while increasing varicosity density
in very young larvae, suggesting developmental influences
on varicosity formation. Time-lapse imaging of serotonergic
neuron-specific markers will resolve whether the effects ofserotonin on varicosity density result from changes in
addition or retraction rates of varicosities. In addition,
serotonin may preferentially effect varicosities of a partic-
ular age/stage of development: one hypothesis is that in L3-
F larvae, older varicosities are stabilized by activity and
insensitive to local serotonin effects, while younger syn-
apses may retract following exposure to serotonin (and/or
activity). We predict that decreasing neuronal activity and
neurotransmitter release should increase varicosity density
in the fly CNS. While inhibition of neurotransmitter release
in Munc18-1 mice does not prevent synapse formation or
disrupt general morphological organization of the brain,
maintenance of neuronal circuits is dependent upon trans-
mitter release (Verhage et al., 2000). The role of neuronal
activity has been shown to be developmentally regulated,
such that activity enhances axonal filapodial dynamics in
young tissues and inhibits motility in older tissues (Tashiro
et al., 2003). In addition, neurotransmitter function may
induce changes in the surrounding neuropil that may have
secondary (feed-back) effects on the developing neuron,
through which pre- and post-synaptic terminals may
coordinate and optimize their position (Cohen-Cory, 2002).Acknowledgments
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